pCVL Traffic Light Reporter 1.1 (Sce target) Ef1a BFP Citations (4)

Originally described in: Tracking genome engineering outcome at individual DNA breakpoints.
Certo MT, Ryu BY, Annis JE, Garibov M, Jarjour J, Rawlings DJ, Scharenberg AM Nat Methods. 2011 Jul 10;8(8):671-6. doi: 10.1038/nmeth.1648. PubMed Journal

---

Articles Citing pCVL Traffic Light Reporter 1.1 (Sce target) Ef1a BFP

Articles
Synergism of Proneurogenic miRNAs Provides a More Effective Strategy to Target Glioma Stem Cells. Kosti A, Barreiro R, Guardia GDA, Ostadrahimi S, Kokovay E, Pertsemlidis A, Galante PAF, Penalva LOF. Cancers (Basel). 2021 Jan 14;13(2). pii: cancers13020289. doi: 10.3390/cancers13020289. PubMed
Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN-driven CCL5 and CXCL10. Mowat C, Mosley SR, Namdar A, Schiller D, Baker K. J Exp Med. 2021 Sep 6;218(9). pii: 212506. doi: 10.1084/jem.20210108. Epub 2021 Jul 23. PubMed
Identification and Validation of New DNA-PKcs Inhibitors through High-Throughput Virtual Screening and Experimental Verification. Dai L, Yu P, Fan H, Xia W, Zhao Y, Zhang P, Zhang JZH, Zhang H, Chen Y. Int J Mol Sci. 2024 Jul 22;25(14):7982. doi: 10.3390/ijms25147982. PubMed
Retinoic acid-induced 2 deficiency impairs genomic stability in breast cancer. Boettcher L, Greimeier S, Borgmann K, Mughal SS, Ellinger B, Bartkowiak K, Zobiak B, Failla AV, Steffen P, Claus E, Besler K, Buccitelli C, Schaaf V, Ozga AK, Parretta S, Schneegans S, Mansour WY, Korbel JO, Schlueter H, Brors B, Pantel K, Wikman H, Werner S. Breast Cancer Res. 2025 Jul 22;27(1):137. doi: 10.1186/s13058-025-02085-8. PubMed

If you have published an article using this material, please email us at to have your article added to this page.